Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment completed in STELLAR 3 pivotal trial of Xyotax

Dec. 1, 2003

Antiangiogenic and antiproliferative effects described for AP-23573 in tumor cells

Dec. 1, 2003

Plenaxis receives FDA approval

Nov. 28, 2003

Introgen and SWOG to evaluate Advexin plus surgery in phase II trial

Nov. 28, 2003

Antisoma and EMD Lexigen create immunocytokine fusion protein

Nov. 28, 2003

Preliminary phase I results on EKB-569 for advanced colorectal cancer

Nov. 28, 2003

ET-743 is associated with changes in the gene expression of sarcoma cells

Nov. 28, 2003

Metvix approved in Switzerland

Nov. 27, 2003

Novel EGFR inhibitors under study at Boehringer Ingelheim

Nov. 27, 2003

Japanese researchers describe protein kinase inhibitors as antineoplastic enhancing agents

Nov. 27, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...